IL111775A - Prolyl endopeptidase inhibitors, their preparation and compositions containing same - Google Patents

Prolyl endopeptidase inhibitors, their preparation and compositions containing same

Info

Publication number
IL111775A
IL111775A IL111775A IL11177594A IL111775A IL 111775 A IL111775 A IL 111775A IL 111775 A IL111775 A IL 111775A IL 11177594 A IL11177594 A IL 11177594A IL 111775 A IL111775 A IL 111775A
Authority
IL
Israel
Prior art keywords
compound
mmol
formula
compounds
acid
Prior art date
Application number
IL111775A
Other languages
English (en)
Other versions
IL111775A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL111775A0 publication Critical patent/IL111775A0/xx
Publication of IL111775A publication Critical patent/IL111775A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL111775A 1993-12-02 1994-11-27 Prolyl endopeptidase inhibitors, their preparation and compositions containing same IL111775A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16110693A 1993-12-02 1993-12-02

Publications (2)

Publication Number Publication Date
IL111775A0 IL111775A0 (en) 1995-01-24
IL111775A true IL111775A (en) 1998-06-15

Family

ID=22579844

Family Applications (1)

Application Number Title Priority Date Filing Date
IL111775A IL111775A (en) 1993-12-02 1994-11-27 Prolyl endopeptidase inhibitors, their preparation and compositions containing same

Country Status (19)

Country Link
US (1) US5661167A (fr)
EP (1) EP0731788B1 (fr)
JP (1) JPH09506090A (fr)
KR (1) KR100341982B1 (fr)
CN (1) CN1136806A (fr)
AT (1) ATE223894T1 (fr)
AU (1) AU684861B2 (fr)
CA (1) CA2177821C (fr)
DE (1) DE69431359T2 (fr)
DK (1) DK0731788T3 (fr)
ES (1) ES2179093T3 (fr)
HU (1) HUT74687A (fr)
IL (1) IL111775A (fr)
NO (1) NO962238D0 (fr)
NZ (1) NZ276600A (fr)
PT (1) PT731788E (fr)
TW (1) TW280818B (fr)
WO (1) WO1995015310A1 (fr)
ZA (1) ZA949302B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
ZA200508439B (en) 2003-05-05 2007-03-28 Probiodrug Ag Medical use of inhibitors of glutaminyl and glutamate cyclases
EP1824846A2 (fr) 2003-11-03 2007-08-29 Probiodrug AG Nouveaux composes pour le traitement de troubles neurologiques
ZA200603165B (en) 2003-11-03 2007-07-25 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
EP1713780B1 (fr) 2004-02-05 2012-01-18 Probiodrug AG Nouveaux inhibiteurs de la glutaminyl-cyclase
WO2008055945A1 (fr) 2006-11-09 2008-05-15 Probiodrug Ag Dérivés 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one utiles en tant qu' inhibiteurs de la glutaminyl-cyclase dans le traitement des ulcères, du cancer et d'autres maladies
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
CN101668525A (zh) 2007-03-01 2010-03-10 前体生物药物股份公司 谷氨酰胺酰环化酶抑制剂的新用途
EP2142514B1 (fr) 2007-04-18 2014-12-24 Probiodrug AG Dérivés de thio-urée utilisés comme inhibiteurs de la glutaminyl cyclase
US8524654B2 (en) * 2007-05-21 2013-09-03 The Uab Research Foundation Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation
SG178953A1 (en) 2009-09-11 2012-04-27 Probiodrug Ag Heterocylcic derivatives as inhibitors of glutaminyl cyclase
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
DK2545047T3 (da) 2010-03-10 2014-07-28 Probiodrug Ag Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5)
WO2011131748A2 (fr) 2010-04-21 2011-10-27 Probiodrug Ag Nouveaux inhibiteurs
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
US9771786B2 (en) 2014-01-28 2017-09-26 Spirit Global Energy Solutions, Inc. Down-hole gas and solids separator utilized in production hydrocarbons
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
CA1341029C (fr) * 1985-02-04 2000-06-20 Michael Kolb Inhibiteurs de la peptidase
DE3712365A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
US4855303A (en) * 1987-07-01 1989-08-08 Pfizer Inc. Fluorine containing renin inhibitors
JPH0662591B2 (ja) * 1988-12-14 1994-08-17 株式会社ヤクルト本社 新規なチオプロリン誘導体
US5118811A (en) * 1989-04-13 1992-06-02 Japan Tobacco Inc. Amino acid derivatives possessing prolyl endopeptidase-inhibitory activities

Also Published As

Publication number Publication date
IL111775A0 (en) 1995-01-24
DK0731788T3 (da) 2003-01-20
KR100341982B1 (ko) 2002-11-30
PT731788E (pt) 2003-01-31
HUT74687A (en) 1997-01-28
AU1091795A (en) 1995-06-19
DE69431359D1 (de) 2002-10-17
NZ276600A (en) 1997-09-22
JPH09506090A (ja) 1997-06-17
ZA949302B (en) 1995-08-07
US5661167A (en) 1997-08-26
ATE223894T1 (de) 2002-09-15
TW280818B (fr) 1996-07-11
CA2177821C (fr) 2000-03-28
CA2177821A1 (fr) 1995-06-08
HU9601472D0 (en) 1996-07-29
WO1995015310A1 (fr) 1995-06-08
NO962238L (no) 1996-05-31
EP0731788A1 (fr) 1996-09-18
ES2179093T3 (es) 2003-01-16
EP0731788B1 (fr) 2002-09-11
NO962238D0 (no) 1996-05-31
AU684861B2 (en) 1998-01-08
CN1136806A (zh) 1996-11-27
DE69431359T2 (de) 2003-07-31

Similar Documents

Publication Publication Date Title
EP0731788B1 (fr) Inhibiteurs de la prolyle endopeptidase
US4692458A (en) Anti-hypertensive agents
US5496927A (en) Peptidase inhibitors
EP0073143B1 (fr) Amido- et imido-dérivés complexes de carboxyalcoyl peptides et thioéthers et éthers de peptide
CA2338524C (fr) Inhibiteurs d'urokinase et de la formation de vaisseaux sanguins
US4745124A (en) Orally effective anti-hypertensive agents
CA2075154A1 (fr) Aldehydes peptidiques utilises comme agents antithrombotiques
WO1993025574A1 (fr) Inhibiteurs d'angiotensine i-chymase(s), comprenant la chymase cardiaque humaine
NZ284766A (en) Perfluoro amino ketones; medicaments as elastase inhibitors
US20020119992A1 (en) Thrombin inhibitors
US4912120A (en) 3,5-substituted 4,5-dihydroisoxazoles as transglutaminase inhibitors
US4929630A (en) Transglutaminase inhibitors
US4766110A (en) Novel complex amido and imido derivatives of carboxyalkyl peptides
Xie et al. New kelatorphan-related inhibitors of enkephalin metabolism: improved antinociceptive properties
JPH10509727A (ja) Ｎ−末端スルホニル−又はアミノスルホニル基を有する新規のジペプチドのｐ−アミノベンジルアミド
US5798377A (en) Thrombin inhibitors
EP0858262B1 (fr) Inhibiteurs de thrombine
JP2004503563A (ja) 凝固因子Ｘａ阻害剤
US6693072B2 (en) Elastase inhibitors
EP0846120A1 (fr) Inhibiteurs de thrombine bicycliques de type uree et de faible poids moleculaire
US20050004100A1 (en) ACE inhibitor derivatives
US4734420A (en) Anti-hypertensive agents
EP0036713B1 (fr) Inhibiteurs d'enzymes transformant de l'angiotensine
US6265381B1 (en) Orally-active elastase inhibitors
US4690936A (en) Anti-hypertensive agents

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees